FierceBiotech 2026年4月16日 Early-stage funding slumps toward post-pandemic low, piling more pressure on biotech startups
FierceBiotech 2026年4月16日 FDA advisory committee set to weigh taking action on certain unapproved peptides
FierceBiotech 2026年4月15日 Was Big Pharma’s ‘unusually aggressive’ M&A spree to blame for March IPO drought?
FierceBiotech 2026年4月15日 Spain sets up Boston-focused VC fund with goal of raising $200M for biotechs
FierceBiotech 2026年4月15日 Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
FierceBiotech 2026年4月15日 Bain-backed Beeline Medicines buzzes out of stealth with $300M and 5 programs from BMS
FierceBiotech 2026年4月15日 FDA official confirms plausible mechanism principles not exclusive to bespoke gene therapies
FierceBiotech 2026年4月14日 Australia’s Kazia pays research institute $1.4M for epigenetic platform, preclinical drug
FierceBiotech 2026年4月14日 Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions
FierceBiotech 2026年4月14日 Harbinger Health raises $100M for new suite of blood-based cancer detection tests
FierceBiotech 2026年4月14日 Boehringer, Amgen discard early immunology candidates over lack of clinical potential
FierceBiotech 2026年4月13日 Kailera outlines plans for $528.5M IPO to support quartet of Chinese obesity assets